{"id":30133,"date":"2017-06-01T12:24:19","date_gmt":"2017-06-01T11:24:19","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=30133"},"modified":"2017-06-01T12:24:19","modified_gmt":"2017-06-01T11:24:19","slug":"els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","title":{"rendered":"Los farmac\u00e9uticos actualizan conocimientos en melatonina y dermatitis at\u00f3pica"},"content":{"rendered":"

El pasado mes de abril tuvieron lugar dos conferencias relacionadas con la dermofarmacia y los productos sanitarios: \u201cNuevas formulaciones en melatonina para prevenir el envejecimiento y el da\u00f1o celular en la piel<\/strong>\u201d (6 de abril) y \u201cNuevos abordajes en el manejo de la dermatitis at\u00f3pica<\/strong>\u201d (27 de abril).<\/p>\n

\"dermofarmacia-abril-cofb<\/a>
Marta Alcalde, vocal de Dermofarmacia y Productos Sanitarios del COFB<\/figcaption><\/figure>\n

En la primera conferencia se abord\u00f3 laenvejecimiento y los efectos de la melatonina a nivel celular y mitocondrial<\/strong>. Francisca Miranda<\/b>, responsable del Departamento de Fabricaci\u00f3n de IUCT, y Germaine Escamas<\/b>, directora cient\u00edfica de Pharmamel y catedr\u00e1tica en Fisiolog\u00eda de la Facultad de Farmacia de Granada, revisaron las funciones de la melatonina en la c\u00e9lula para prevenir el envejecimiento actuando desde su interior.<\/p>\n

\u201cEscamas lleva m\u00e1s de 25 a\u00f1os estudiando los efectos de la melatonina a nivel celular y mitocondrial y desde su experiencia nos hizo una exposici\u00f3n muy t\u00e9cnica donde habl\u00f3 de todo el proceso de envejecimiento de las c\u00e9lulas y de la piel, y de c\u00f3mo la melatonina tiene unos efectos demostrados como antioxidante, antiinflamatorio y proinflamatorio. Estos efectos de la melatonina lo hacen un activo muy interesante en procesos de envejecimiento cut\u00e1neo y tambi\u00e9n por tratar problemas derivados de tratamientos oncol\u00f3gicos como la mucositis y la radiodermitis<\/strong>\u201d explica Marta Alcalde, vocal de Dermofarmacia y Productos sanitarios del COFB<\/strong>, que moder\u00f3 la conferencia.<\/p>\n

\u201cAparte de los efectos cosm\u00e9ticos contra el envejecimiento, estas posibles aplicaciones m\u00e9dicas -una vez superados los diferentes estudios cl\u00ednicos donde se encontraban los productos- pueden ser muy interesantes para aliviar problemas muy molestos por los enfermos que padecen estas enfermedades<\/strong>. Todos estos estudios de eficacia vinieron corroborados Miranda, del Departamento de Fabricaci\u00f3n del IUCT, que es la empresa externa que se ha encargado de realizarlos\u201d matiza Alcalde.<\/div>\n

\u00a0\"dermofarmacia-abril-cofb<\/a><\/p>\n

Por otra parte, la dermatitis at\u00f3pica<\/a><\/b> es una de las patolog\u00edas dermatol\u00f3gicas de consulta m\u00e1s frecuentes en la oficina de farmacia, y por tanto el papel del farmac\u00e9utico a la hora de hacer seguimiento de los tratamientos prescritos y recomendaciones de higiene e hidrataci\u00f3n, con el objetivo de aligerar los s\u00edntomas y espaciar los brotes, es muy importante.<\/p>\n

\"dermofarmacia-abril-cofb-formacio<\/a>
Esther Serra-Baldrich (Hospital de San Pablo de Barcelona)<\/figcaption><\/figure>\n

El tratamiento cosm\u00e9tico de la dermatitis at\u00f3pica se basa en una combinaci\u00f3n de emolientes t\u00f3picos para restaurar la barrera protectora de la piel<\/strong>. Las futuras estrategias dermocosm\u00e9ticas contemplan el tratamiento personalizado adaptado a la situaci\u00f3n de cada paciente con el objetivo de reducir los efectos secundarios de los tratamientos farmacol\u00f3gicos y los episodios de brote. En la segunda conferencia, se revisaron los diferentes abordajes de la atopia y conoceremos la experiencia cl\u00ednica en la utilizaci\u00f3n de nuevos activos como el plancton marino.<\/p>\n

La conferencia cont\u00f3 como ponentes con elEsther Serra-Baldrich<\/b>, responsable de la Unidad de Inmunoalergia Cut\u00e1nea del Hospital de San Pablo de Barcelona, que habl\u00f3 de la enfermedad y los diferentes tratamientos que existen para abordarla, tanto de los cl\u00e1sicos como de las nuevas mol\u00e9culas como el fitoplancton y de las que en un futuro tendremos. \u201cDi\u00f3 mucha importancia a qu\u00e9 no hay un tratamiento est\u00e1ndar, sino que debe personalizarse mucho en cada paciente<\/strong>, y tambi\u00e9n a que todos los tratamientos son compatibles entre s\u00ed: como la dermatitis at\u00f3pica tiene una sintomatolog\u00eda muy variada cada tratamiento puede servir para atacar un punto en concreto pero a la vez todos son complementarios<\/strong>\u201d explica Alcalde<\/strong>. \u201cLa Dra. en Tecnolog\u00eda de los Alimentos, Pilar Ram\u00edrez<\/b>, habl\u00f3 sobre que es el fitoplancton marino, c\u00f3mo se extrae y cu\u00e1l es su actividad contra el estr\u00e9s oxidativo y por tanto c\u00f3mo puede ayudar a la regeneraci\u00f3n de la piel, en estos procesos que cursan con una gran xerosis y descamaci\u00f3n\u201d.<\/div>\n

\"dermofarmacia-abril-cofb-formacio<\/a><\/p>\n

\"AP-poster\"<\/a>La vocal de Dermofarmacia del COFB, Marta Alcalde<\/strong>, tambi\u00e9n present\u00f3 una de las tres Jornadas de Psoriasis y Artritis Psori\u00e1sica,<\/strong> que acogi\u00f3 el Colegio el 17 de mayo. Acci\u00f3n Psoriasis<\/a> conmemora en tres ciudades la fecha de su nacimiento, organizando encuentros informativos en los que hace llegar la informaci\u00f3n sobre la patolog\u00eda a pacientes y familiares<\/strong>. Las reuniones tienen como objetivo resolver las dudas de los asistentes, gracias a la participaci\u00f3n de especialistas en psoriasis y artritis psori\u00e1sica de cada una de las zonas en las que estamos presentes. Las jornadas se organizan en colaboraci\u00f3n con los Colegios Oficiales de Farmac\u00e9uticos y con los Colegios Oficiales de Enfermer\u00eda de las ciudades en las que se celebran.<\/strong><\/p>\n

Pr\u00f3xima jornada: hoy en C\u00e1diz<\/strong> (1 de junio). M\u00e1s informaci\u00f3n aqu\u00ed<\/a>. <\/div>\n

Con la colaboraci\u00f3n de:<\/b><\/p>\n

Conferencia melatonina<\/p>\n

\"logo-pharmamel\"<\/a><\/p>\n

\n

\n

Conferencia dermatitis at\u00f3pica<\/p>\n

\"logo-dds\"<\/a><\/p>","protected":false},"excerpt":{"rendered":"

El pasado mes de abril tuvieron lugar dos conferencias relacionadas con la dermofarmacia y los productos sanitarios: \u201cNuevas formulaciones en melatonina para prevenir el envejecimiento y el da\u00f1o celular en la piel\u201d (6 de abril) y \u201cNuevos abordajes en el manejo de la dermatitis at\u00f3pica\u201d (27 de abril). En la primera conferencia se [\u2026]<\/p>","protected":false},"author":1,"featured_media":30141,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[802,209,213,81,707,53,70,2758,237,231],"class_list":["post-30133","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-accio-psoriasi","tag-artritis-psoriasica","tag-dermatitis-atopica","tag-dermofarmacia","tag-envelliment","tag-farmaceutics","tag-formacio","tag-melatonina","tag-productes-sanitaris","tag-psoriasi"],"yoast_head":"\nEls farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica<\/title>\n<meta name=\"description\" content=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" \/>\n<meta property=\"og:description\" content=\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-01T11:24:19+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\",\"datePublished\":\"2017-06-01T11:24:19+00:00\",\"dateModified\":\"2017-06-01T11:24:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\"},\"wordCount\":863,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Acci\u00f3 Psoriasi\",\"artritis psori\u00e0sica\",\"dermatitis at\u00f2pica\",\"Dermofarm\u00e0cia\",\"envelliment\",\"farmac\u00e8utics\",\"Formaci\u00f3\",\"melatonina\",\"productes sanitaris\",\"psoriasi\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\",\"name\":\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2017-06-01T11:24:19+00:00\",\"dateModified\":\"2017-06-01T11:24:19+00:00\",\"description\":\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","description":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","og_locale":"es_ES","og_type":"article","og_title":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","og_description":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","og_url":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2017-06-01T11:24:19+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","datePublished":"2017-06-01T11:24:19+00:00","dateModified":"2017-06-01T11:24:19+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/"},"wordCount":863,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage"},"thumbnailUrl":"","keywords":["Acci\u00f3 Psoriasi","artritis psori\u00e0sica","dermatitis at\u00f2pica","Dermofarm\u00e0cia","envelliment","farmac\u00e8utics","Formaci\u00f3","melatonina","productes sanitaris","psoriasi"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","url":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/","name":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage"},"thumbnailUrl":"","datePublished":"2017-06-01T11:24:19+00:00","dateModified":"2017-06-01T11:24:19+00:00","description":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2017\/06\/01\/els-farmaceutics-actualitzen-coneixements-en-melatonina-dermatitis-atopica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Els farmac\u00e8utics actualitzen coneixements en melatonina i dermatitis at\u00f2pica"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat mes d\u2019abril van tenir lloc dues confer\u00e8ncies relacionades amb la dermofarm\u00e0cia i els productes sanitaris: \u201cNoves formulacions en melatonina per prevenir l’envelliment i el dany cel\u00b7lular a la pell\u201d (6 d\u2019abril) i \u201cNous abordatges en el maneig de la dermatitis at\u00f2pica\u201d (27 d\u2019abril). A la primera confer\u00e8ncia es […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/30133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=30133"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/30133\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=30133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=30133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=30133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}